Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways

被引:51
|
作者
Yao, Honghong [1 ]
Allen, James E. [1 ]
Zhu, Xuhui [1 ]
Callen, Shannon [1 ]
Buch, Shilpa [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA
关键词
gp120; cocaine; HIV-1-associated neurological disorders; neurotoxicity; primary neurons; NADPH OXIDASE; TRANSCRIPTION FACTORS; CHEMOKINE RECEPTOR; APOPTOSIS; ACTIVATION; PROTEIN; EXPRESSION; NEURONS; ERK; ENHANCEMENT;
D O I
10.1080/13550280902755375
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although it has been well documented that drugs of abuse such as cocaine cause enhanced progression of human immunodeficiency virus (HIV)-associated neuropathological disorders, the underlying mechanisms mediating these effects remain poorly understood. The present study demonstrated that exposure of rat primary neurons to both cocaine and gp120 resulted in increased cell toxicity compared to cells treated with either factor alone. The combinatorial toxicity of cocaine and gp120 was accompanied by an increase in both caspase-3 activity and expression of the proapoptotic protein Bax. Furthermore, increased neurotoxicity in the presence of both the agents was associated with a concomitant increase in the production of intracellular reactive oxygen species and loss of mitochondrial membrane potential. Increased neurotoxicity mediated by cocaine and gp120 was ameliorated by NADPH oxidase inhibitor apocynin, thus underscoring the role of oxidative stress in this cooperation. Signaling pathways including c-jun N-teminal kinase (JNK), p38, extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinases (MAPK), and nuclear factor (NF)-B were also identified to be critical in the neurotoxicity induced by cocaine and gp120. These findings thus underscore the role of oxidative stress, mitochondrial and MAPK signal pathways in cocaine and HIV gp120-mediated neurotoxicity.
引用
收藏
页码:164 / 175
页数:12
相关论文
共 50 条
  • [31] Human immunodeficiency virus type 1 envelope protein gp120 impairs intracellular antifungal mechanisms in human monocytes
    Pietrella, D
    Monari, C
    Retini, C
    Palazzetti, B
    Bistoni, F
    Vecchiarelli, A
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (02): : 347 - 354
  • [32] Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein
    Wyatt, R
    Desjardin, E
    Olshevsky, U
    Nixon, C
    Binley, J
    Olshevsky, V
    Sodroski, J
    JOURNAL OF VIROLOGY, 1997, 71 (12) : 9722 - 9731
  • [33] Gp120 in the Pathogenesis of Human Immunodeficiency Virus-Associated Pain
    Yuan, Su-Bo
    Shi, Yuqiang
    Chen, Jinghong
    Zhou, Xiangfu
    Li, Guangyu
    Gelman, Benjamin B.
    Lisinicchia, Joshua G.
    Carlton, Susan M.
    Ferguson, Monique R.
    Tan, Alai
    Sarna, Sushil K.
    Tang, Shao-Jun
    ANNALS OF NEUROLOGY, 2014, 75 (06) : 837 - 850
  • [34] THE GP120 GLYCOPROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BINDS TO SENSORY GANGLION NEURONS
    APOSTOLSKI, S
    MCALARNEY, T
    QUATTRINI, A
    LEVISON, SW
    ROSOKLIJA, G
    LUGARESSI, A
    CORBO, M
    SADIQ, SA
    LEDERMAN, S
    HAYS, AP
    LATOV, N
    ANNALS OF NEUROLOGY, 1993, 34 (06) : 855 - 863
  • [35] Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries
    Ferrer, M
    Harrison, SC
    JOURNAL OF VIROLOGY, 1999, 73 (07) : 5795 - 5802
  • [36] CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 BINDING TO LIPOSOMES CONTAINING GALACTOSYLCERAMIDE
    LONG, D
    BERSON, JF
    COOK, DG
    DOMS, RW
    JOURNAL OF VIROLOGY, 1994, 68 (09) : 5890 - 5898
  • [37] HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 CHALLENGE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT ENVELOPE GLYCOPROTEIN GP120
    BERMAN, PW
    GROOPMAN, JE
    GREGORY, T
    CLAPHAM, PR
    WEISS, RA
    FERRIANI, R
    RIDDLE, L
    SHIMASAKI, C
    LUCAS, C
    LASKY, LA
    EICHBERG, JW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) : 5200 - 5204
  • [38] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZATION IS DETERMINED BY EPITOPE EXPOSURE ON THE GP120 OLIGOMER
    SATTENTAU, QJ
    MOORE, JP
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01): : 185 - 196
  • [39] Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120
    Hong, Patrick W. -P.
    Nguyen, Sandra
    Young, Sophia
    Su, Stephen V.
    Lee, Benhur
    JOURNAL OF VIROLOGY, 2007, 81 (15) : 8325 - 8336
  • [40] Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus
    Nagashunmugam, T
    Malamud, D
    Davis, C
    Abrams, WR
    Friedman, HM
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06): : 1635 - 1641